Pharmacokinetics and Safety Evaluation of Maribavir in Healthy Japanese and Matched White Participants: A Phase I, Open ‐Label Study

This study demonstrated higher maribavir systemic exposure in Japanese than White participants and similar s afety outcomes. This difference in exposure is not considered clinically important and its significance remains to be determined.
Source: Clinical Pharmacology in Drug Development - Category: Drugs & Pharmacology Authors: Tags: Original Article Source Type: research